You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 10, October 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Childhood enuresis. II. Psychopathology, tricyclic concentration in plasma, and antienuretic effect

J. L. Rapoport, E. J. Mikkelsen, A. Zavadil, L. Nee, C. Gruenau, W. Mendelson and J. C. Gillin

The efficacy of treatment with imipramine hydrochloride, desipramine hydrochloride, methscopolamine bromide, and placebo was compared in a study with 40 severely enuretic boys. Both tricyclic antidepressants were superior to placebo and methscopolamine, but they did not differ from each other. Psychiatric disturbance, sleep measures, and other clinical parameters did not predict antienuretic response to tricyclics nor was there a psychotropic response. Plasma concentrations of imipramine and desipramine showed a significant correlation with clinical effect. However, true nonresponders were found, and tolerance to the antienuretic drugs developed in some boys.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Perspectives in Primary Nocturnal Enuresis
Gimpel et al.
CLIN PEDIATR 1998;37:23-29.
ABSTRACT  

Older Pharmacologic Therapy for Nocturnal Enuresis
Gil Rushton
CLIN PEDIATR 1993;32:10-13.
ABSTRACT  

Risk/Benefit Ratio in Enuresis Therapy
Fitzwater and Macknin
CLIN PEDIATR 1992;31:308-310.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.